Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 572.67 billion as of August 14, 2025. Its market cap has increased by 40.90% in one year.

Market Cap

572.67B

Enterprise Value

580.34B

Revenue

134.35B

Ranking

n/a

PE Ratio

54.70

Stock Price

2,044.60

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 572.67B, an increase of 49,727.59%. That is a compound annual growth rate of 29.26%.

Market Cap History

Date	Market Cap	% Change
Aug 13, 2025	572.67B	26.12%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	139.25B	42.03%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	3,859.09B
Divi's Laboratories	1,582.46B
Cipla	1,229.07B
Apollo Hospitals Enterprise	1,043.73B
Mankind Pharma	1,006.03B
Zydus Lifesciences	961.61B
Fortis Healthcare	695.05B
Aurobindo Pharma	611.53B

Market Cap Rankings